These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26476704)

  • 1. Increased expression of NDEL1 and MBP genes in the peripheral blood of antipsychotic-naïve patients with first-episode psychosis.
    Ota VK; Noto C; Santoro ML; Spindola LM; Gouvea ES; Carvalho CM; Santos CM; Xavier G; Higuchi CH; Yonamine C; Moretti PN; Abílio VC; Hayashi MA; Brietzke E; Gadelha A; Cordeiro Q; Bressan RA; Belangero SI
    Eur Neuropsychopharmacol; 2015 Dec; 25(12):2416-25. PubMed ID: 26476704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in gene expression and methylation in the blood of patients with first-episode psychosis.
    Ota VK; Noto C; Gadelha A; Santoro ML; Spindola LM; Gouvea ES; Stilhano RS; Ortiz BB; Silva PN; Sato JR; Han SW; Cordeiro Q; Bressan RA; Belangero SI
    Schizophr Res; 2014 Nov; 159(2-3):358-64. PubMed ID: 25270546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis.
    Noto C; Ota VK; Santoro ML; Gouvea ES; Silva PN; Spindola LM; Cordeiro Q; Bressan RA; Gadelha A; Brietzke E; Belangero SI; Maes M
    Mol Neurobiol; 2016 Oct; 53(8):5701-9. PubMed ID: 26491028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.
    Gouvea ES; Ota VK; Noto C; Santoro ML; Spindola LM; Moretti PN; Carvalho CM; Xavier G; Rios AC; Sato JR; Hayashi MA; Brietzke E; Gadelha A; Bressan RA; Cordeiro Q; Belangero SI
    Transl Psychiatry; 2016 Oct; 6(10):e908. PubMed ID: 27701407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
    Dal Mas C; Nani JV; Noto C; Yonamine CM; da Cunha GR; Mansur RB; Ota VK; Belangero SI; Cordeiro Q; Kapczinski F; Brietzke E; Bressan RA; Gadelha A; Hayashi MAF
    Schizophr Res; 2019 Jun; 208():202-208. PubMed ID: 30857875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naïve patients with first-episode psychosis.
    Ota VK; Noto C; Gadelha A; Santoro ML; Ortiz BB; Andrade EH; Tasso BC; Spindola LM; Silva PN; Abílio VC; Smith Mde A; Sato JR; Brietzke E; Cordeiro Q; Bressan RA; Belangero SI
    J Psychiatr Res; 2014 Sep; 56():130-6. PubMed ID: 24935901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.
    Noto C; Ota VK; Gouvea ES; Rizzo LB; Spindola LM; Honda PH; Cordeiro Q; Belangero SI; Bressan RA; Gadelha A; Maes M; Brietzke E
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone.
    Noto C; Ota VK; Gadelha A; Noto MN; Barbosa DS; Bonifácio KL; Nunes SO; Cordeiro Q; Belangero SI; Bressan RA; Maes M; Brietzke E
    J Psychiatr Res; 2015 Sep; 68():210-6. PubMed ID: 26228421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.
    de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Jung-Cook H; Solís-Vivanco R; Graff-Guerrero A; Shungu DC
    Biol Psychiatry; 2018 Mar; 83(6):475-483. PubMed ID: 29132653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic treatment reduces psychotic symptoms and markers of low-grade inflammation in first episode psychosis patients, but increases their body mass index.
    Haring L; Koido K; Vasar V; Leping V; Zilmer K; Zilmer M; Vasar E
    Schizophr Res; 2015 Dec; 169(1-3):22-29. PubMed ID: 26364730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis.
    Mantere O; Trontti K; García-González J; Balcells I; Saarnio S; Mäntylä T; Lindgren M; Kieseppä T; Raij T; Honkanen JK; Vaarala O; Hovatta I; Suvisaari J
    J Psychiatr Res; 2019 Feb; 109():18-26. PubMed ID: 30463035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naïve first-episode psychosis patients before and after antipsychotic treatment.
    Ota VK; Noto C; Gadelha A; Santoro ML; Silva PN; Melaragno MI; Smith Mde A; Cordeiro Q; Bressan RA; Belangero SI
    Psychiatry Res; 2013 Dec; 210(3):1290-2. PubMed ID: 24113126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.
    Goff DC; Zeng B; Ardekani BA; Diminich ED; Tang Y; Fan X; Galatzer-Levy I; Li C; Troxel AB; Wang J
    JAMA Psychiatry; 2018 Apr; 75(4):370-378. PubMed ID: 29466532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of NDEL1 oligopeptidase activity in blood and brain in an animal model of schizophrenia: effects of psychostimulants and antipsychotics.
    Nani JV; Lee RS; Yonamine CM; Sant'Anna OA; Juliano MA; Gadelha A; Mari JJ; Hayashi MAF
    Sci Rep; 2020 Oct; 10(1):18513. PubMed ID: 33116174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging biological markers in a cohort of antipsychotic-naïve first-episode psychosis patients.
    Talarico F; Xavier G; Ota VK; Spindola LM; Maurya PK; Tempaku PF; Moretti PS; Gadelha A; Noto M; Noto C; Cordeiro Q; Bressan RA; de Jong S; Santoro ML; Breen G; Belangero SI
    Psychoneuroendocrinology; 2021 Oct; 132():105350. PubMed ID: 34271521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis.
    Noto MN; Maes M; Nunes SOV; Ota VK; Rossaneis AC; Verri WA; Cordeiro Q; Belangero SI; Gadelha A; Bressan RA; Noto C
    Eur Neuropsychopharmacol; 2019 Mar; 29(3):416-431. PubMed ID: 30594344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach.
    Castro-Fornieles J; Parellada M; Soutullo CA; Baeza I; Gonzalez-Pinto A; Graell M; Paya B; Moreno D; de la Serna E; Arango C
    J Child Adolesc Psychopharmacol; 2008 Aug; 18(4):327-36. PubMed ID: 18759642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.
    Stevenson JM; Reilly JL; Harris MS; Patel SR; Weiden PJ; Prasad KM; Badner JA; Nimgaonkar VL; Keshavan MS; Sweeney JA; Bishop JR
    Transl Psychiatry; 2016 Feb; 6(2):e739. PubMed ID: 26905411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.